https://ph-ksp.com/cereno-scientific-announces-partnership-with-pha-europe-on-patient-centered-pulmonary-hypertension-drug-design-may-11-2026/ 2026-05-22T16:08:41Z PULMONARY HYPERTENSION en Cereno Scientific announces partnership with PHA Europe on patient-centered pulmonary hypertension drug design, May 11, 2026 2026-05-22T04:01:18Z Blog https://ph-ksp.com/thirty-years-of-progress-in-pulmonary-hypertension-treatment-from-despair-to-hope-chinese-medical-journal-may-19-2026/ 2026-05-22T03:46:01Z PULMONARY HYPERTENSION en Thirty Years of Progress in Pulmonary Arterial Hypertension Treatment: From Despair to Hope, Chinese Medical Journal, May 19, 2026 2026-05-22T03:44:54Z Blog https://ph-ksp.com/efficacy-and-safety-of-sotatercept-in-patients-with-pulmonary-arterial-hypertension-pah-associated-with-connective-tissue-disease-ctd-ats-international-conference-may-18-2026/ 2026-05-22T03:27:00Z PULMONARY HYPERTENSION en Efficacy and safety of sotatercept in patients with pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD), ATS international conference, May 18, 2026 2026-05-22T03:26:59Z Blog